The Vigabatrin REMS Program is required by the FDA to ensure educated risk-benefit decisions prior to initiating therapy, and to ensure ideal use vigabatrin while patients are dealt with. When vision loss will happen, it is not possible for your health care provider to know.
The most common side effect of SABRIL in children 3 to 16 years is weight gain. With serious vision loss, you may just be able to see things right in front of you (sometimes called tunnel vision"). You are at risk for vision loss with any type of quantity of SABRIL.
Tell your healthcare provider if you are pregnant or mean to obtain pregnant. If vision screening can not be done, your healthcare provider might continue prescribing SABRIL, yet will not be able to watch for any vision loss. Your healthcare company might stop prescribing SABRIL for you (or your youngster)if vision examinations are not done routinely.